A Study of AK104/Placebo Plus AK109/Placebo And Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma

Conditions: Gastric and Gastroesophageal Junction Adenocarcinoma Interventions: Drug: cadonilimab; Drug: pulocimab; Drug: paclitaxel; Drug: placebo Sponsors: Akeso Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials